Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-11 Purchase | 2023-08-14 4:30 pm | Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co Shenandoah Acquisition Corp 10% Owner | 1,718,493 | $14.92 | $25,639,916 | 100 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-08-11 Equity Swap | 2023-08-15 4:15 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner | 797,720 | $14.92 | 0 (Indirect) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2026-07-13 | Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director | 4,273 | $7.51 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 341 | $0 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2026-07-13 | Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director | 3,754 | $7.51 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 12,690 | $0.75 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 1,925 | $0 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director | 683 | $4.9984 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director | 683 | $6.6439 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 8,845 | $0.75 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 8,846 | $0.75 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 2,884 | $0 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 35,382 | $0.75 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 12,169 | $0 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER | 10,767 | $0.75 | 0 (Direct) | View |
2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER | 3,504 | $0 | 0 (Direct) | View |
2023-07-27 Exercise | 2023-07-27 4:21 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 2,884 | $19.24 | 9,230 (Direct) | View |
2023-07-27 Exercise | 2023-07-27 4:21 pm | N/A 2032-03-06 | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 2,884 | $0 | 9,230 (Direct) | View |
2023-07-21 Exercise | 2023-07-24 7:45 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER | 1,444 | $19.24 | 6,425 (Direct) | View |
2023-07-21 Exercise | 2023-07-24 7:45 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER | 1,444 | $0 | 6,425 (Direct) | View |
2023-07-21 Exercise | 2023-07-24 7:44 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 5,528 | $19.24 | 24,126 (Direct) | View |
2023-07-21 Exercise | 2023-07-24 7:44 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 5,528 | $0 | 24,126 (Direct) | View |
Ownership | 2023-07-07 4:30 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co Shenandoah Acquisition Corp 10% Owner | 0 | $0 | 211,110 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 8,888 | $0 | 8,888 (Direct) | View |
2023-02-28 Option Award | 2023-03-01 4:46 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 165,000 | $0 | 165,000 (Direct) | View |
2023-02-28 Option Award | 2023-03-01 4:43 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO | 460,000 | $0 | 460,000 (Direct) | View |
2023-02-28 Option Award | 2023-03-01 4:41 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER | 140,000 | $0 | 140,000 (Direct) | View |
2023-02-28 Option Award | 2023-03-01 4:38 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 115,000 | $0 | 115,000 (Direct) | View |
2023-02-28 Option Award | 2023-03-01 4:36 pm | N/A 2033-02-27 | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 115,000 | $0 | 115,000 (Direct) | View |
Ownership | 2023-03-01 4:35 pm | N/A N/A | Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO | 0 | $0 | 343,570 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:01 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:01 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:01 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cox John Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Story Brooke Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 8,888 | $0 | 8,888 (Direct) | View |
2022-04-01 Option Award | 2022-04-04 4:50 pm | N/A 2032-03-06 | Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO | 120,000 | $0 | 120,000 (Direct) | View |
2022-02-18 Option Award | 2022-02-22 5:01 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER | 90,000 | $1.48 | 90,000 (Direct) | View |
2022-02-18 Option Award | 2022-02-22 5:00 pm | N/A 2032-02-17 | Sigilon Therapeutics Inc. | SGTX | Pontes Josias ACTING CHIEF FINANCIAL OFFICE | 60,000 | $1.48 | 60,000 (Direct) | View |